These expanded offerings add medical-grade LDPE, nylon, PEBA, PS and PVC to the globally available palette of specialty healthcare colorants, and are pre-certified to meet or exceed biocompatibility requirements for ISO 10993 and/or USP Class VI protocols.

As a complement to PolyOne’s liquid Excelite CFA portfolio for extrusion, new Excelite IM CFAs are engineered for a wide range of injection molded polymers, including olefins, PVC, polystyrene, PC/ABS, and high-heat materials.

Our polymer portfolio features corrosion-resistant PVC, CPVC and glass-filled vinyl composites that will more than meet your needs. 

Supply chain security: The supply for PVC dispersion resin can be volatile and, when supply gets tight, smaller plastisol producers are often affected the most.

Our range of world-class services includes: Color Technology: Custom color design, saturated colors, and special effects to fill market niches and eliminate secondary operations Color & Design Services: Trend and color insights, and product development assistance to optimize design and gain speed to market Regulatory Coordination: Aid with new product approvals to reduce regulatory overhead and minimize risk Field Technical Service: Support for tool design, startup and production optimization to gain manufacturing efficiencies Sustainability: Innovative materials and solutions to help you meet your sustainability goals To learn more visit www.avient.com or call 1.844.4AVIENT (1.844.428.4368) B&C Industry Bulletin B&C Industry Bulletin_Single Pages

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as concentrates or ready-to-use formulations in a wide range of polymers • Functionality and color can be combined in one product for convenience REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Documentation support for approval or transition to comply with (new) regulations such as IVDR APPLICATION BULLETIN Healthcare use limitations apply—see below.

TECHNOLOGY BENEFITS • Improved light blocking performance up to 99.9% at 550nm and 700nm • Brighter whiteness L* >90 even in thin wall sections (0.21mm) • Plug & go solution—processes similar to virgin PET • Process with standard PET grades and rPET • Reduces equipment wear and tear • TiO2 content of

Versaflex™ & Versalloy™ Specialty Engineered Materials Thermoplastic Elastomers for Healthcare Applications Delivering specialized thermoplastic elastomer (TPE) solutions for demanding healthcare applications, Avient has performance-grade materials that are approved for USP VI, ISO 10993-4 and 10993-5.

Thereafter, Buyer automatically approves the invoice. Buyer shall be exclusively responsible for (i) ensuring compliance with all Laws and Standards associated with its intended use of Product; and (ii) obtaining all necessary approvals, permits or clearances for such use. license or approval.

Purchase price multiple rapidly declining on strength of business and synergy capture 7 $133 $201 2019PF 2022E 7 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies 11.9% 16.3% 2019PF 2022E EBITDA Margins CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 8 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 9 Commercial Resources Operating Income Operating Margins 259 363 $40 $139 Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 46% 67% 86% 100% 0% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 10 Building & 43% 14% Telecom. 2% 2006 2022 Pro Forma 21% Building & Telecom.